BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19211771)

  • 1. Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes.
    Dong C; Kwas C; Wu L
    J Virol; 2009 Apr; 83(8):3518-27. PubMed ID: 19211771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
    Liou LY; Herrmann CH; Rice AP
    J Virol; 2002 Nov; 76(21):10579-87. PubMed ID: 12368300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.
    Sawaya BE; Khalili K; Gordon J; Taube R; Amini S
    J Biol Chem; 2000 Nov; 275(45):35209-14. PubMed ID: 10931842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant.
    Gao G; Wu X; Zhou J; He M; He JJ; Guo D
    J Biol Chem; 2013 May; 288(20):14297-14309. PubMed ID: 23569210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9.
    Mameli G; Deshmane SL; Ghafouri M; Cui J; Simbiri K; Khalili K; Mukerjee R; Dolei A; Amini S; Sawaya BE
    J Gen Virol; 2007 Feb; 88(Pt 2):631-640. PubMed ID: 17251582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat.
    Jadlowsky JK; Nojima M; Schulte A; Geyer M; Okamoto T; Fujinaga K
    Retrovirology; 2008 Jul; 5():63. PubMed ID: 18620576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive activity between the trans-activation response RNA-binding protein, TRBP2, and cyclin T1 on HIV type 1 expression and viral production in murine cells.
    Battisti PL; Daher A; Bannwarth S; Voortman J; Peden KW; Hiscott J; Mouland AJ; Benarous R; Gatignol A
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):767-78. PubMed ID: 14585207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.
    Hamasaki T; Okamoto M; Baba M
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1323-31. PubMed ID: 23274668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
    Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
    J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.
    Garber ME; Wei P; KewalRamani VN; Mayall TP; Herrmann CH; Rice AP; Littman DR; Jones KA
    Genes Dev; 1998 Nov; 12(22):3512-27. PubMed ID: 9832504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
    Fujinaga K; Irwin D; Geyer M; Peterlin BM
    J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
    Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
    J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    J Virol; 1999 Jul; 73(7):5777-86. PubMed ID: 10364329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes.
    Martin-Serrano J; Li K; Bieniasz PD
    J Virol; 2002 Jan; 76(1):208-19. PubMed ID: 11739686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines.
    Herrmann CH; Carroll RG; Wei P; Jones KA; Rice AP
    J Virol; 1998 Dec; 72(12):9881-8. PubMed ID: 9811724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant negative mutant cyclin T1 proteins that inhibit HIV transcription by forming a kinase inactive complex with Tat.
    Jadlowsky JK; Nojima M; Okamoto T; Fujinaga K
    J Gen Virol; 2008 Nov; 89(Pt 11):2783-2787. PubMed ID: 18931076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.